TSE:APHA Aphria - APHA Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Aphria Inc. Please log in to your account or sign up in order to add this asset to your watchlist. C$16.55 -0.98 (-5.59%) (As of 05/4/2021) Add Compare Share Share Today's RangeC$16.41▼C$17.5250-Day RangeC$16.55▼C$16.5552-Week RangeC$3.93▼C$40.93Volume9.61 million shsAverage Volume6.16 million shsMarket CapitalizationC$5.24 billionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileAnalyst RatingsChartCompetitorsHeadlinesOptions ChainSocial Media About Aphria (TSE:APHA) StockAphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands. It serves patients and consumers through distributors and online. The company is headquartered in Leamington, Canada.Read More Receive APHA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aphria and its competitors with MarketBeat's FREE daily newsletter. Email Address APHA Stock News HeadlinesOctober 7, 2022 | finance.yahoo.comGlobal Legal Cannabis Market Report 2022-2030 Featuring Gw Pharmaceuticals, Aurora, Aphria, Cronos, Tilray, Sundial Growers, Insys Therapeutics, Scotts Co, Vivo Cannabis, & Cara Therapeutics - Yahoo FinanceOctober 1, 2022 | benzinga.comGlobal Cannabis Extract Market to Reach $15.5 Billion by 2030 at a CAGR of 20.6% - BenzingaMarch 21, 2023 | Behind the Markets (Ad)BREAKING: Tiny biotech successfully treats blindnessThere's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.September 30, 2022 | globenewswire.comGlobal Medical Marijuana Market Report 2022-2030: Surge in the Number of Countries Legalizing the Usage of Medical Marijuana - GlobeNewswireSeptember 26, 2022 | globenewswire.comGlobal Legal Cannabis Market Analysis Report 2022: A $134.4 Billion Industry by 2030, Growing at a CAGR of Over 25% - GlobeNewswireSeptember 21, 2022 | globenewswire.comGlobal Cannabis Extract Market Report 2022: Elimination of the Black Market Through the Legalization of Medical Cannabis Drives Growth - GlobeNewswireSeptember 8, 2022 | investing.comTilray Simply Needs To Do Better | investing.com - Investing.comSeptember 1, 2022 | seekingalpha.comTilray Brands: No One Is Happy (NASDAQ:TLRY) - Seeking AlphaMarch 21, 2023 | Behind the Markets (Ad)BREAKING: Tiny biotech successfully treats blindnessThere's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.August 30, 2022 | theglobeandmail.comCannabis producer Tilray lays off at least 22 migrant farm workers - The Globe and MailAugust 25, 2022 | globenewswire.comTilray Medical Launches New Products and 'CannaPoints' - GlobeNewswireAugust 16, 2022 | businesswire.comNorth America Legal Marijuana Market Size, Share & Trends Analysis Report 2022-2030 - ResearchAndMarkets.com - Business WireAugust 2, 2022 | benzinga.comCanopy Growth Taps Ex Aphria Executive Christelle Gedeon As New Chief Legal Officer - BenzingaJuly 25, 2022 | fool.ca3 Stocks That Have Flopped Hard This Year - The Motley Fool CanadaJune 25, 2022 | nasdaq.com5 Growth Stocks to Buy for 5-Bagger Returns in 5 Years - NasdaqJune 22, 2022 | streetinsider.comTilray Medical Welcomes Government of Luxembourg Delegation Visit to European Campus in Portugal - StreetInsider.comJune 13, 2022 | forbes.comA Sneak Preview Of Diplo And Rob Dyrdek’s New Cannabis Seltzers, Leisuretown - ForbesMay 17, 2022 | seekingalpha.comTilray Brands: Almost Good Enough - Seeking AlphaMay 12, 2022 | fool.comDown 80% From Its High, Can Tilray Stock Spark Again? - The Motley FoolApril 14, 2022 | thestreet.comTilray Stock: Experts Forecast More Than 20% Upside Potential - TheStreetApril 5, 2022 | fool.com3 Huge Things to Watch in Tilray's Q3 Earnings Report This Week - The Motley FoolMarch 25, 2022 | thestreet.comWith Marijuana Legalization In Sight, Tilray Stock Could Be A Major Beneficiary - TheStreetMarch 13, 2022 | fool.comIs Tilray Making a Colossal Mistake? - The Motley FoolJanuary 14, 2022 | investorplace.comWhy Tilray Stock Is Starting to Look Interesting - InvestorPlaceJanuary 6, 2022 | 247wallst.comEarnings Previews: Albertsons, Commercial Metals, Tilray - 24/7 Wall St.January 4, 2022 | investorplace.comTilray Isn't Your Cannabis Bet for the Long-Haul - InvestorPlaceDecember 23, 2021 | benzinga.comCorporate Cannabis Takeover? Assessing 5 Big Industries Already At The Table - Benzinga - BenzingaSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive APHA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aphria and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeTSE Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolTSE:APHA CUSIPN/A CIKN/A Webwww.aphria.com Phone844-427-4742FaxN/AEmployees1,200Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio59.29 Current Ratio3.37 Quick Ratio1.63 Sales & Book Value Annual SalesC$611.06 million Price / Sales8.58 Cash FlowC$0.74 per share Price / Cash Flow22.40 Book ValueC$4.76 per share Price / Book3.48Miscellaneous Outstanding Shares316,795,000Free FloatN/AMarket CapC$5.24 billion OptionableOptionable BetaN/A Key ExecutivesMr. Irwin D. Simon (Age 62)CEO & Chairman Comp: $6.54MMr. Carl A. MertonChief Financial OfficerDr. Christelle Gedeon L.L.B.Ph.D., Chief Legal Officer & Corp. Sec.Mr. James R. MeiersChief Operating Officer of Aphria LeamingtonMs. Denise Menikheim Faltischek (Age 48)Chief Strategy Officer & MD of Aphria Germany Comp: $562.35kMr. John B. SadlerVP of Investor RelationsMr. Bernard YeungSr. VP of Sales & MarketingMr. Victor Neufeld (Age 67)Special Advisor Mr. Cole Cacciavillani (Age 66)Special Advisor Mr. Randy DaigneauSr. VP of Supply ChainMore ExecutivesKey CompetitorsBausch Health CompaniesTSE:BHCCanopy GrowthTSE:WEEDValeant Pharmaceuticals InternationalTSE:VRXTrillium TherapeuticsTSE:TRILdentalcorpTSE:DNTLView All Competitors APHA Stock - Frequently Asked Questions How have APHA shares performed in 2023? Aphria's stock was trading at C$16.55 at the beginning of 2023. Since then, APHA stock has increased by 0.0% and is now trading at C$16.55. View the best growth stocks for 2023 here. What other stocks do shareholders of Aphria own? Based on aggregate information from My MarketBeat watchlists, some companies that other Aphria investors own include Aurora Cannabis (ACB), Canopy Growth (WEED), Aurora Cannabis (ACB), Organigram (OGI), KushCo (KSHB), NVIDIA (NVDA), CannTrust (CTST), Cronos Group (CRON) and Cronos Group (CRON). What is Aphria's stock symbol? Aphria trades on the Toronto Stock Exchange (TSX) under the ticker symbol "APHA." How do I buy shares of Aphria? Shares of APHA stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What is Aphria's stock price today? One share of APHA stock can currently be purchased for approximately C$16.55. How much money does Aphria make? Aphria (TSE:APHA) has a market capitalization of C$5.24 billion and generates C$611.06 million in revenue each year. How many employees does Aphria have? The company employs 1,200 workers across the globe. How can I contact Aphria? Aphria's mailing address is 245 Talbot St W Suite 103, LEAMINGTON, ON N8H 1N8, Canada. The official website for the company is www.aphria.com. The company can be reached via phone at 844-427-4742. This page (TSE:APHA) was last updated on 3/21/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.